MAR 11, 2019 9:12 PM PDT

PARP Inhibitors Boost Immune Efficacy

WRITTEN BY: Nouran Amin

In a recent research study, precision cancer drugs called PARP inhibitors are previously known to boost the immune system were found to spark a powerful immune response when used against cancer cells with weaknesses in DNA repair.

Image: Purple lung cancer cells. Credit: Anne Weston, Francis Crick Institute. Licence: CC BY-NC 4.0

"The findings of this study substantially change our understanding of how PARP inhibitors work. We now know that they not only kill tumors by damaging their DNA, but also by attracting immune cells to attack them -- acting as a sort of double-pronged attack. Immunotherapy is a genuinely brilliant cancer treatment but generally only for the 10 to 20 percent of people who respond to it. Finding the tumour is half of the battle in immunotherapy so by attracting the immune cells to the tumour, PARP inhibitors could enable the immunotherapy drug to target their attack,” says Chris Lord, Professor of Cancer Genomics at The Institute of Cancer Research in London.

Learn more:

Findings of the study were published in the Journal of Clinical Investigation and changes the current understanding on PARP inhibitors and their potential role in cancer treatments alongside immunotherapies. Particularly, certain PARP inhibitors, like olaparib, block a mechanism that cells use to repair DNA.

"Our study found that PARP inhibitors enlist immune cells to aid in the killing of cancer cells. This provides a rationale for using PARP inhibitors alongside immunotherapies to further stimulate the immune response to cancer cells with DNA repair defects and enhance the therapeutic benefit of the treatment. This will be evaluated in a clinical trial of lung, prostate and bladder cancers, which is starting later this year,” says study co-leader Dr. Sophie Postel-Vinay, Clinician Scientist and Medical Oncologist at Gustave Roussy, France, and The Institute of Cancer Research.

Source: The Institute of Cancer Research

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 13, 2020
Immunology
Early Tips For Cell & Gene Therapy Regulatory Compliance
OCT 13, 2020
Early Tips For Cell & Gene Therapy Regulatory Compliance
Cell and gene therapies hold great promise for improved health outcomes. Now is the time to advance life-saving research ...
OCT 12, 2020
Cancer
Targeting Energy Production in Cells to Fight Leukemia
OCT 12, 2020
Targeting Energy Production in Cells to Fight Leukemia
Much like how a car needs gasoline to run, cells also need a fuel source. Most human cells in the body use oxidative pho ...
NOV 01, 2020
Cannabis Sciences
Can Cannabis Treat ALS?
NOV 01, 2020
Can Cannabis Treat ALS?
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative illness that damages motor neurons and leads to progressive m ...
NOV 08, 2020
Cannabis Sciences
Can Cannabis Treat Epilepsy?
NOV 08, 2020
Can Cannabis Treat Epilepsy?
There has been growing interest in recent years for cannabis to treat central nervous system disorders. And so far, ther ...
NOV 18, 2020
Cancer
Could Targeting the Proteasome be Effective Against Cancer?
NOV 18, 2020
Could Targeting the Proteasome be Effective Against Cancer?
One of the trickiest things about anti-cancer drug design is targeting. Today, most drugs on the market target critical ...
NOV 09, 2020
Drug Discovery & Development
Can Oxidants Slow Down Cellular Aging?
NOV 09, 2020
Can Oxidants Slow Down Cellular Aging?
Oxidants are reactive oxygen species known to be harmful to living organisms at high concentrations and have been linked ...
Loading Comments...